Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC00373, or Long intergenic non-protein coding RNA 373, is a human lincRNA gene, meaning it produces a long RNA transcript (>200 nucleotides) that does not overlap with protein-coding gene regions and is not translated into protein[1][3][5]. The general class of lincRNAs appears to regulate gene expression and cell phenotype in specific contexts, but direct evidence for LINC00373’s function, involvement with disease, or viability as a therapeutic target is lacking in current databases and research[1][3][5]. LINC00373 is annotated in genomic databases (GeneCards, NCBI, Ensembl), but its biological or clinical significance, interacting molecules, and potential as a drug target remain uncharacterized at this time[1][3]. Key limitations: - No functional, disease-related, or drug interaction data is reported for this specific lincRNA. - The gene is correctly named and classified as a long intergenic non-protein coding RNA, but has not been established as a therapeutic target in research or clinical practice[1][3][5].
Not applicable (no targeted drugs, mechanisms unknown for this specific lincRNA)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 373 (LINC00373).